Literature DB >> 16406096

Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.

S Djibo1, B-M Njanpop Lafourcade, P Boisier, A Moussa, G Kobo, F Sidikou, A Hien, G Bieboure, J-F Aguilera, I Parent du Chatelet, B D Gessner, S Chanteau.   

Abstract

The recent emergence of Neisseria meningitidis W135 as a cause of epidemic bacterial meningitis and the availability of a trivalent ACW135 vaccine have created a need for accurate and timely meningococcal serogroup determination for organization of epidemic vaccine response. The sensitivity and specificity of the Pastorex meningitis kit (Bio-Rad) to identify serogroups A and W135 in the African meningitis belt was assessed using PCR testing as the gold standard. The sensitivity and specificity for serogroups A and W135 were 87 and 85%, respectively, while the specificities were 93 and 97%. The positive and negative likelihood ratios for A were 12 and 0.14 and for W135 were 33 and 0.16. The positive and negative predictive values, computed to simulate an epidemic of meningococcal meningitis with an estimated 70% prevalence of N. meningitidis among suspected cases, were 97% and 75% for A and 99% and 73% for W135. In remote locations of the African meningitis belt, latex agglutination is the only currently available test that can rapidly determine meningococcal serogroup. This study showed that latex agglutination performs well and could be used during the epidemic season to determine appropriate vaccine response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406096     DOI: 10.1016/j.trstmh.2005.10.002

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.

Authors:  Suzanne Chanteau; Sylvie Dartevelle; Ali Elhadj Mahamane; Saacou Djibo; Pascal Boisier; Farida Nato
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

2.  Evaluation of Pastorex meningitis kit performance for the rapid identification of Neisseria meningitidis serogroup C in Nigeria.

Authors:  Kennedy Uadiale; Agatha Bestman; Charity Kamau; Dominique A Caugant; Jane Greig
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-07       Impact factor: 2.184

3.  Diagnosis of bacterial meningitis in Ghana: Polymerase chain reaction versus latex agglutination methods.

Authors:  Nafiu Amidu; Benedict Boateng Antuamwine; Otchere Addai-Mensah; Abass Abdul-Karim; Azure Stebleson; Braimah Baba Abubakari; John Abenyeri; Afia Serwaa Opoku; John Eyulaku Nkukah; Ali Sidi Najibullah
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

4.  The Role of Molecular Testing in Pediatric Meningitis Surveillance in Southern and East African Countries, 2008-2017.

Authors:  Mignon du Plessis; Linda de Gouveia; Cesar Freitas; Negga Asamene Abera; Budiaki Sylvie Lula; Julia Liliane Raboba; Aquino Albino Nhantumbo; Elana Jantjies; Jeannine Uwimana; Nomcebo Phungwayo; Gugu Maphalala; Gilbert Masona; John Muyombe; David Mugisha; Esther Nalumansi; Moses Odongkara; Chileshe Lukwesa-Musyani; Ruth Nakazwe; Vongai Dondo; John Macharaga; Goitom G Weldegebriel; Jason M Mwenda; Fatima Serhan; Adam L Cohen; Fernanda C Lessa; Anne von Gottberg
Journal:  J Infect Dis       Date:  2021-09-01       Impact factor: 5.226

5.  Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger.

Authors:  Angela M C Rose; Sibylle Gerstl; Ali E-H Mahamane; Fati Sidikou; Saacou Djibo; Laurence Bonte; Dominique A Caugant; Philippe J Guerin; Suzanne Chanteau
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

6.  Meningitis serogroup W135 outbreak, Burkina Faso, 2002.

Authors:  Nicolas Nathan; Angela M C Rose; Dominique Legros; Sylvestre R M Tiendrebeogo; Catherine Bachy; Egil Bjørløw; Peter Firmenich; Philippe J Guerin; Dominique A Caugant
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.